Clinical Trial Update: Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating imatinib (Gleevec) and gemcitabine (Gemzar) in patients with epithelial ovarian cancer and primary peritoneal cancer has completed, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Gleevec (Imatinib)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-21